Skip to main content
. 2019 Apr 15;11(4):544. doi: 10.3390/cancers11040544

Figure 6.

Figure 6

Flowchart summarizing conclusions of the study. Three molecular subgroups based on IDH mutation, 1p/19q co-deletion and CHI3L1 and NTRK2 gene expression status were identified and showed distinct clinical presentations with different prognoses.